Management of patients co-infected with HBV and HCV

Expert Review of Anti-Infective Therapy

Volumn 7, Issue 5, 2009, Pages 549-558

  Coffin, Carla S ^b   Terrault, Norah A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Antiviral treatment; Co infection; HBV; HCV

Indexed keywords

ENTECAVIR; HEPATITIS B SURFACE ANTIGEN; INTERFERON; LAMIVUDINE; NUCLEOSIDE ANALOG; PEGINTERFERON; RIBAVIRIN; TENOFOVIR; VIRUS DNA; ANTIVIRUS AGENT; RECOMBINANT INTERFERON; VIRUS RNA;

CLINICAL PROTOCOL; CLINICAL TRIAL; DIAGNOSTIC TEST; DISEASE ACTIVITY; DISEASE TRANSMISSION; DRUG EFFICACY; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; MIXED INFECTION; MONITORING; NONHUMAN; REVIEW; RISK ASSESSMENT; SUPERINFECTION; VIRUS REPLICATION; BLOOD; HETEROZYGOTE; LIVER TUMOR; RISK FACTOR; TREATMENT OUTCOME; VIROLOGY;

ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; CARRIER STATE; DNA, VIRAL; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; INTERFERON TYPE I, RECOMBINANT; LIVER CIRRHOSIS; LIVER NEOPLASMS; RIBAVIRIN; RISK FACTORS; RNA, VIRAL; SUPERINFECTION; TREATMENT OUTCOME;

EID: 68249141906     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/ERI.09.38     Document Type: Review

References (63)

1. Gaeta GB, Stornaiuolo G, Precone DF et al. Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian study. J. Hepatol. 39, 1036-1041 (2003). (Pubitemid 37523777)
2. Pallas J, Farinas-Alvarez C, Prieto D, Llorca J, Delgado-Rodriguez M. Risk factors for mono-infections and co-infections with HIV, hepatitis B and hepatitis C viruses in northern Spanish prisoners. Epidemiol. Infect. 123, 95-102 (1999). (Pubitemid 29412860)
3. Pallas JR, Farinas-Alvarez C, Prieto D, Delgado-Rodriguez M. Co-infections by HIV, hepatitis B and hepatitis C in imprisoned injecting drug users. Eur. J. Epidemiol. 15, 699-704 (1999). (Pubitemid 29493108)
4. Aroldi A, Lampertico P, Montagnino G et al. Natural history of hepatitis B and C in renal allograft recipients. Transplantation 79, 1132-1136 (2005). (Pubitemid 40664010)
5. Zhou J, Dore GJ, Zhang F, Lim PL, Chen YM. Hepatitis B and C virus co-infection in The TREAT Asia HIV Observational Database. J. Gastroenterol. Hepatol. 22, 1510-1518 (2007). (Pubitemid 47274591)
6. Crespo J, Lozano JL, de la Cruz F et al. Prevalence and significance of hepatitis C viremia in chronic active hepatitis B. Am. J. Gastroenterol. 89, 1147-1151 (1994). (Pubitemid 24245785)
7. Fattovich G, Tagger A, Brollo L et al. Hepatitis C virus infection in chronic hepatitis B virus carriers. J. Infect. Dis. 163, 400-402 (1991).
8. Chan CY, Lee SD, Wu JC et al. Superinfection with hepatitis C virus in patients with symptomatic chronic hepatitis B. Scand. J. Infect. Dis. 23, 421-424 (1991).
9. Liaw Y-F, Yeh-C-T, Tsai S-L. Impact of acute hepatitis B virus superinfection on chronic hepatitis C virus infection. Am. J. Gastroenterol. 95, 2978-2980 (2000).
10. Raimondo G, Allain JP, Brunetto MR et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J. Hepatol. 49, 652-657 (2008).
11. Liaw YF. Hepatitis C virus superinfection in patients with chronic hepatitis B virus infection. J. Gastroenterol. 37(Suppl. 13), 65-68 (2002).
12. Liaw YF, Chen YC, Sheen IS, Chien RN, Yeh CT, Chu CM. Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection. Gastroenterology 126, 1024-1029 (2004).
13. Guido M, Rugge M, Colombari R, Cecchetto A, Scarpa A, Cadrobbi P. Prompt hepatitis C virus suppression following hepatitis B virus superinfection in chronic untreated hepatitis C. Ital. J. Gastroenterol. Hepatol. 30, 414-417 (1998). (Pubitemid 28445786)
14. Wietzke P, Schott P, Braun F, Mihm S, Ramadori G. Clearance of HCV RNA in a chronic hepatitis C virus-infected patient during acute hepatitis B virus superinfection. Liver 19, 348-353 (1999). (Pubitemid 29359101)
15. Sagnelli E, Coppola N, Messina V et al. HBV superinfection in hepatitis C virus chronic carriers, viral interaction and clinical course. Hepatology 36, 1285-1291 (2002). (Pubitemid 35253448)
16. Coffin CS, Mulrooney-Cousins PM, Lee SS, Michalak TI, Swain MG. Profound suppression of chronic hepatitis C following superinfection with hepatitis B virus. Liver Int. 27, 722-726 (2007).
17. Mimms LT, Mosley JW, Hollinger FB et al. Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection. BMJ 307, 1095-1097 (1993).
18. Chu CM, Liaw YF. Simultaneous acute hepatitis B virus and hepatitis C virus infection leading to fulminant hepatitis and subsequent chronic hepatitis C. Clin. Infect. Dis. 20, 703-705 (1995).
19. Sagnelli E, Coppola N, Scolastico C et al. Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and d viruses in patients with chronic hepatitis. Hepatology 32, 1106-1110 (2000). (Pubitemid 30808437)
20. Alberti A, Clumeck N, Collins S et al. Short statement of the first European consensus conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. J. Hepatol. 42, 615-624 (2005). (Pubitemid 40501675)
21. Lee LP, Dai CY, Chuang WL et al. Comparison of liver histopathology between chronic hepatitis C patients and chronic hepatitis B and C-co-infected patients. J. Gastroenterol. Hepatol. 22, 515-517 (2007).
22. Zarski JP, Bohn B, Bastie A et al. Characteristics of patients with dual infection by hepatitis B and C viruses. J. Hepatol. 28, 27-33 (1998). (Pubitemid 28122496)
23. Benvegnu L, Fattovich G, Noventa F et al. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer 74, 2442-2448 (1994). (Pubitemid 24320846)
24. Chiaramonte M, Stroffolini T, Vian A et al. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer 85, 2132-2137 (1999). (Pubitemid 29215551)
25. Donato F, Boffetta P, Puoti M. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int. J. Cancer 75, 347-354 (1998). (Pubitemid 28100034)
26. Benvegnu L, Alberti A. Patterns of hepatocellular carcinoma development in hepatitis B virus and hepatitis C virus related cirrhosis. Antiviral Res. 52, 199-207 (2001). (Pubitemid 32042650)
27. Huo TI, Huang YH, Hsia CY et al. Characteristics and outcome of patients with dual hepatitis B and C-associated hepatocellular carcinoma: are they different from patients with single virus infection? Liver Int. 29(5), 767-773 (2008).
28. Fan CL, Wei L, Jiang D et al. Spontaneous viral clearance after 6-21 years of hepatitis B and C viruses co-infection in high HBV endemic area. World J. Gastroenterol. 9, 2012-2016 (2003). (Pubitemid 37168433)
29. Shiratori Y, Shiina S, Zhang PY et al. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan? Cancer 80, 2060-2067 (1997). (Pubitemid 27506018)
30. Fukuda R, Ishimura N, Hamamoto S et al. Co-infection by serologically-silent hepatitis B virus may contribute to poor interferon response in patients with chronic hepatitis C by down-regulation of type-I interferon receptor gene expression in the liver. J. Med. Virol. 63, 220-227 (2001). (Pubitemid 32116477)
31. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N. Engl. J. Med. 341, 22-26 (1999). (Pubitemid 29293716)
32. Sagnelli E, Coppola N, Scolastico C, Mogavero AR, Filippini P, Piccinino F. HCV genotype and 'silent' HBV coinfection: two main risk factors for a more severe liver disease. J. Med. Virol. 64, 350-355 (2001). (Pubitemid 32565132)
33. Giannini E, Ceppa P, Botta F et al. Previous hepatitis B virus infection is associated with worse disease stage and occult hepatitis B virus infection has low prevalence and pathogenicity in hepatitis C virus-positive patients. Liver Int. 23, 12-18 (2003). (Pubitemid 37265769)
34. Chu CM, Sheen IS, Liaw YF. Low-level hepatitis C viremia and humoral immune response to NS4 in chronic hepatitis B virus-hepatitis C virus co-infection. Scand. J. Gastroenterol. 39, 778-782 (2004).
35. Raimondo G, Brunetto MR, Pontisso P et al. Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B/hepatitis C virus-co-infected patients. Hepatology 43, 100-107 (2006). (Pubitemid 43733596)
36. Alberti A, Pontisso P, Chemello L et al. The interaction between hepatitis B virus and hepatitis C virus in acute and chronic liver disease. J. Hepatol. 22, 38-41 (1995).
37. Coppola N, Pisapia R, Tonziello G et al. Virological pattern in plasma, peripheral blood mononuclear cells and liver tissue and clinical outcome in chronic hepatitis B and C virus co-infection. Antivir. Ther. 13, 307-318 (2008).
38. Rodríguez-Íñigo E, Bartolomé J, Movilla-Ortiz N et al. Hepatitis C virus (HCV) and hepatitis B virus (HBV) can co-infect the same hepatocyte in the liver of patients with chronic HCV and occult HBV infection. J. Virol. 79, 15578-15581 (2005). (Pubitemid 43032340)
39. Shih CM, Lo SJ, Miyamura T, Chen SY, Lee YH. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J. Virol. 67, 5823-5832 (1993). (Pubitemid 23277490)
40. Chen S-Y, Kao C-F, Chen C-M et al. Mechanisms for inhibition of hepatitis B virus gene expression and replication by hepatitis C virus core protein. J. Biol. Chem. 278, 591-607 (2003).
41. Schuttler CG, Fiedler N, Schmidt K, Repp R, Gerlich WH, Schaefer S. Suppression of hepatitis B virus enhancer 1 and 2 by hepatitis C virus core protein. J. Hepatol. 37, 855-862 (2002). (Pubitemid 35404227)
42. Chu CJ, Lee SD. Hepatitis B virus/ hepatitis C virus co-infection: epidemiology, clinical features, viral interactions and treatment. J. Gastroenterol. Hepatol. 23, 512-520 (2008).
43. Chisari FV. Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B. Am. J. Pathol. 156, 1117-1132 (2000).
44. Liu CJ, Chen PJ, Lai MY, Kao JH, Jeng YM, Chen DS. Ribavirin and interferon is effective for hepatitis C virus clearance in hepatitis B and C dually infected patients. Hepatology 37, 568-576 (2003).
45. Guptan RC, Thakur V, Raina V, Sarin SK. α-interferon therapy in chronic hepatitis due to active dual infection with hepatitis B and C viruses. J. Gastroenterol. Hepatol. 14, 893-898 (1999). (Pubitemid 29459799)
46. Liaw YF, Chien RN, Lin SM et al. Response of patients with dual hepatitis B virus and C virus infection to interferon therapy. J. Interferon Cytokine Res. 17, 449-452 (1997).
47. Villa E, Grottola A, Buttafoco P et al. High doses of a-interferon are required in chronic hepatitis due to co-infection with hepatitis B virus and hepatitis C virus: long term results of a prospective randomized trial. Am. J. Gastroenterol. 96, 2973-2977 (2001). (Pubitemid 32962579)
48. Weltman MD, Brotodihardjo A, Crewe EB et al. Co-infection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-α treatment. J. Viral Hepat. 2, 39-45 (1995).
49. Potthoff A, Wedemeyer H, Boecher WO et al. The HEP-NET B/C co-infection trial: a prospective multicenter study to investigate the efficacy of pegylated interferon-α2b and ribavirin in patients with HBV/HCV co-infection. J. Hepatol. 49, 688-694 (2008).
50. Saitta C, Pontisso P, Brunetto MR et al. Virological profiles in hepatitis B virus/hepatitis C virus co-infected patients under interferon plus ribavirin therapy. Antivir. Ther. 11, 931-934 (2006). (Pubitemid 44736185)
51. Senturk H, Tahan V, Canbakan B et al. Chronic hepatitis C responds poorly to combination therapy in chronic hepatis B carriers. Neth. J. Med. 66, 191-195 (2008). (Pubitemid 351771999)
52. Liu CJ, Chuang WL, Lee CM et al. Peginterferon α-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses. Gastroenterology 136(2), 496-504 (2008).
53. Marrone A, Zampino R, D'Onofrio M, Ricciotti R, Ruggiero G, Utili R. Combined interferon plus lamivudine treatment in young patients with dual HBV (HBeAg positive) and HCV chronic infection. J. Hepatol. 41, 1064-1065 (2004). (Pubitemid 39575680)
54. Chuang WL, Dai CY, Chang WY et al. Viral interaction and responses in chronic hepatitis C and B co-infected patients with interferon-a plus ribavirin combination therapy. Antivir. Ther. 10, 125-133 (2005).
55. Hung CH, Lee CM, Lu SN et al. Combination therapy with interferon-α and ribavirin in patients with dual hepatitis B and hepatitis C virus infection. J. Gastroenterol. Hepatol. 20, 727-732 (2005).
56. Utili R, Zampino R, Bellopede P et al. Dual or single hepatitis B and C virus infections in childhood cancer survivors: long-term follow-up and effect of interferon treatment. Blood 94, 4046-4052 (1999).
57. de Franchis R, Hadengue A, Lau G et al. EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002 Geneva, Switzerland. Consensus statement (long version). J. Hepatol. 39(Suppl. 1), S3-S25 (2003).
58. Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 49, 1335-1374 (2008).
59. Strader DB, Wright T, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C. Hepatology 39, 1147-1171 (2004).
60. Liaw YF, Leung N, Guan R et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update. Liver Int. 25, 472-489 (2005). (Pubitemid 40861895)
61. Lok AS. Navigating the maze of hepatitis B treatments. Gastroenterology 132, 1586-1594 (2007).
62. WHO. Epidemic and Pandemic Alert and Response (EPR). www.who.int/csr/ disease/hepatitis/en
63. WHO. Epidemic and Pandemic Alert and Response (EPR). Hepatitis C. www.who.int/csr/disease/hepatitis/whocdscsrlyo2003/en/index.html